• Clinical Trials - Liver Transplant

    Study Objective Contact
    A 24 Month, Randomized, Controlled, Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus Plus Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplants [LCID Study Number: 2014-032] Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus Plus Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplants Principal Investigator(s):
    Elizabeth A. Pomfret, MD, PhD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Agnes P. Trabucco,
    Erick Marangos.
    Impact of IL-28B Gene Polymorphism on Outcome of Patients Undergoing Liver Transplantation for Hepatitis C [LCID Study Number: 2012-073] The purpose of this study is to collect data on favorable donor-recipient pairing, grafts, genotypes and patient outcomes. Principal Investigator(s):
    Fredric D. Gordon, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Fredric D. Gordon, MD.